Apresoline Articles
Deerfield ups NitroMed unsolicited takeover offer
19 January 2009
NitroMed to sell BiDil business to JHP
3 November 2008
NAACP attacks lack of BiDil Medicare coverage
5 February 2007
FDA confirms no drugs equivalent to BiDil
15 May 2006
US minority coalition to aid pharma access
11 July 2005
US docs back Rx ethnic/racial group targeting
4 July 2005
NitroMed's BiDil closer to US FDA approval
27 June 2005
NitroMed's BiDil achieves Ph III goals
26 July 2004
NitroMed acquires BiDil NDA for CHF therapy
22 September 1999
FDA Clears SB's Carvedilol For CHF
9 June 1997
AHCPR Guidelines On Heart Failure Management
27 February 1995
BOEH-MANNHEIM TO SELL MEDCO'S BIDIL
22 November 1993
BOOTS' FLOSEQUINAN IN FURTHER TROUBLE?
14 June 1993
Showing 1-15 of 15 articles
- 1
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
